HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
15 hedge funds and large institutions have $4M invested in Hepion Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
15
Holders Change
-1
Holders Change %
-6.25%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
4
Closed
2
Calls
$21K
Puts
–
Net Calls
+$21K
Net Calls Change
-$25K
Top Buyers
1 |
AC
Armistice Capital
New York
|
+$1.98M |
2 |
Osaic Holdings
Scottsdale,
Arizona
|
+$10.9K |
3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$9.8K |
Top Sellers
1 |
OCA
Octagon Capital Advisors
New York
|
-$437K |
2 |
Renaissance Technologies
New York
|
-$140K |
3 |
Morgan Stanley
New York
|
-$51.1K |
4 |
UBS Group
Zurich,
Switzerland
|
-$28K |
5 |
BlackRock
New York
|
-$14K |